Tiline Pharma
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
13-08
micro format · 13 days late
04-08
Gazette deed
Registered office moved from Edegem to HovePower of attorney3 points ▸
Gazette deed
Registered office moved from Edegem to Hove
Power of attorney3 points ▸
- Registered-office move, Azalealei 43. 2540 Hove
- Power of attorney, Marie Decloedt
- Power of attorney, Indra Vanderstuyft
2025
26-06
micro format · 35 days before the deadline
2024
31-12
Financial
Highest result from 2023 to 2025net €25,277 ▲1,312%
The operating result of €35,233 and the net result of €25,277 are both a record.
26-08
micro format · 26 days late
2022
08-12
Gazette deed
IncorporationStarting capital €5,000 · Appointment: VANDER BORGHT Eline Karin Nathalie (director) · Founder7 points ▸
Gazette deed
Incorporation
Starting capital €5,000 · Appointment: VANDER BORGHT Eline Karin Nathalie (director) · Founder7 points ▸
- Incorporation, 03-12-2022
- Founder, VANDER BORGHT Eline Karin Nathalie
- Founding capital, €5,000
- Registered office clause, “2560 Edegem, ter Voortlaan 101” (deed in Dutch)
- Board rule, 1
- Director appointment, VANDER BORGHT Eline Karin Nathalie (director (not named in the articles))
- Pre-incorporation commitments
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Tiline Pharma was incorporated on 6 December 2022 as a private limited company by two natural persons, with a starting capital of €5,000.12 The registered office was moved to Hove in 2026.3 Since 2022, Eline Vander Borght has served as director.4 Total assets rose from €14,176 in 2023 to €71,491 in 2025.5